REPORT ID 2049

Asia-Pacific Antibacterial Drug Resistance Market Report 2017

Publish Date
7-Dec-17
Pages
125
Format
Electronic (PDF)

In this report, the Asia-Pacific Antibacterial Drug Resistance market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Antibacterial Drug Resistance for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Antibacterial Drug Resistance market competition by top manufacturers/players, with Antibacterial Drug Resistance sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    AAIPharma Services
    ANTABIO
    Abgentis
    Abbott Laboratories
    Absynth Biologics
    Achaogen
    Acino Holdings
    Aventis Pharma
    Austell Laboratories
    Assembly Biosciences
    Arpida
    Demuris
    Evolva Holding
    ContraFect
    Cerexa
    GSK
    InterMune
    Isis Pharmaceuticals
    Lyndra
    Microbecide
    Morphochem
    Nabriva Therapeutics
    NanoSafe Coatings
    Novexel
    Osel
    PENDOPHARM
    Pfizer
    VenatoRx Pharmaceuticals

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Telavancin (Vibativ)
    Ceftaroline Fosamil (Teflaro/ Zinforo)
    Fidaxomicin (Dificid / Dificlir)
    Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
    Dalbavancin (Dalvance/ Xydalba)
    Tedizolid Phosphate (Sivextro)
    Oritavancin (Orbactiv/ Nuvocid)
    Ceftolozane-Tazobactam (Zerbaxa)
    Ceftazidime-Avibactam (Avycaz/ Zavicefta)
    PHASE III DRUGS

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Antibacterial Drug Resistance for each application, includin
    Gram-Positive
    Gram-Negative

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Antibacterial Drug Resistance Market Report 2017
1 Antibacterial Drug Resistance Overview
    1.1 Product Overview and Scope of Antibacterial Drug Resistance
    1.2 Classification of Antibacterial Drug Resistance by Product Category
        1.2.1 Asia-Pacific Antibacterial Drug Resistance Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Antibacterial Drug Resistance Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Telavancin (Vibativ)
        1.2.4 Ceftaroline Fosamil (Teflaro/ Zinforo)
        1.2.5 Fidaxomicin (Dificid / Dificlir)
        1.2.6 Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
        1.2.7 Dalbavancin (Dalvance/ Xydalba)
        1.2.8 Tedizolid Phosphate (Sivextro)
        1.2.9 Oritavancin (Orbactiv/ Nuvocid)
        1.2.10 Ceftolozane-Tazobactam (Zerbaxa)
        1.2.11 Ceftazidime-Avibactam (Avycaz/ Zavicefta)
        1.2.12 PHASE III DRUGS
    1.3 Asia-Pacific Antibacterial Drug Resistance Market by Application/End Users
        1.3.1 Asia-Pacific Antibacterial Drug Resistance Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Gram-Positive
        1.3.3 Gram-Negative
    1.4 Asia-Pacific Antibacterial Drug Resistance Market by Region
        1.4.1 Asia-Pacific Antibacterial Drug Resistance Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Antibacterial Drug Resistance (2012-2022)
        1.5.1 Asia-Pacific Antibacterial Drug Resistance Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Antibacterial Drug Resistance Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Antibacterial Drug Resistance Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Antibacterial Drug Resistance Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Antibacterial Drug Resistance Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Antibacterial Drug Resistance (Volume and Value) by Type
        2.2.1 Asia-Pacific Antibacterial Drug Resistance Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Antibacterial Drug Resistance Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Antibacterial Drug Resistance (Volume) by Application
    2.4 Asia-Pacific Antibacterial Drug Resistance (Volume and Value) by Region
        2.4.1 Asia-Pacific Antibacterial Drug Resistance Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Antibacterial Drug Resistance Revenue and Market Share by Region (2012-2017)

3 China Antibacterial Drug Resistance (Volume, Value and Sales Price)
    3.1 China Antibacterial Drug Resistance Sales and Value (2012-2017)
        3.1.1 China Antibacterial Drug Resistance Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
        3.1.3 China Antibacterial Drug Resistance Sales Price Trend (2012-2017)
    3.2 China Antibacterial Drug Resistance Sales Volume and Market Share by Type
    3.3 China Antibacterial Drug Resistance Sales Volume and Market Share by Application

4 Japan Antibacterial Drug Resistance (Volume, Value and Sales Price)
    4.1 Japan Antibacterial Drug Resistance Sales and Value (2012-2017)
        4.1.1 Japan Antibacterial Drug Resistance Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Antibacterial Drug Resistance Sales Price Trend (2012-2017)
    4.2 Japan Antibacterial Drug Resistance Sales Volume and Market Share by Type
    4.3 Japan Antibacterial Drug Resistance Sales Volume and Market Share by Application

5 South Korea Antibacterial Drug Resistance (Volume, Value and Sales Price)
    5.1 South Korea Antibacterial Drug Resistance Sales and Value (2012-2017)
        5.1.1 South Korea Antibacterial Drug Resistance Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Antibacterial Drug Resistance Sales Price Trend (2012-2017)
    5.2 South Korea Antibacterial Drug Resistance Sales Volume and Market Share by Type
    5.3 South Korea Antibacterial Drug Resistance Sales Volume and Market Share by Application

6 Taiwan Antibacterial Drug Resistance (Volume, Value and Sales Price)
    6.1 Taiwan Antibacterial Drug Resistance Sales and Value (2012-2017)
        6.1.1 Taiwan Antibacterial Drug Resistance Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Antibacterial Drug Resistance Sales Price Trend (2012-2017)
    6.2 Taiwan Antibacterial Drug Resistance Sales Volume and Market Share by Type
    6.3 Taiwan Antibacterial Drug Resistance Sales Volume and Market Share by Application

7 India Antibacterial Drug Resistance (Volume, Value and Sales Price)
    7.1 India Antibacterial Drug Resistance Sales and Value (2012-2017)
        7.1.1 India Antibacterial Drug Resistance Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
        7.1.3 India Antibacterial Drug Resistance Sales Price Trend (2012-2017)
    7.2 India Antibacterial Drug Resistance Sales Volume and Market Share by Type
    7.3 India Antibacterial Drug Resistance Sales Volume and Market Share by Application

8 Southeast Asia Antibacterial Drug Resistance (Volume, Value and Sales Price)
    8.1 Southeast Asia Antibacterial Drug Resistance Sales and Value (2012-2017)
        8.1.1 Southeast Asia Antibacterial Drug Resistance Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Antibacterial Drug Resistance Sales Price Trend (2012-2017)
    8.2 Southeast Asia Antibacterial Drug Resistance Sales Volume and Market Share by Type
    8.3 Southeast Asia Antibacterial Drug Resistance Sales Volume and Market Share by Application

9 Australia Antibacterial Drug Resistance (Volume, Value and Sales Price)
    9.1 Australia Antibacterial Drug Resistance Sales and Value (2012-2017)
        9.1.1 Australia Antibacterial Drug Resistance Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Antibacterial Drug Resistance Sales Price Trend (2012-2017)
    9.2 Australia Antibacterial Drug Resistance Sales Volume and Market Share by Type
    9.3 Australia Antibacterial Drug Resistance Sales Volume and Market Share by Application

10 Asia-Pacific Antibacterial Drug Resistance Players/Suppliers Profiles and Sales Data
    10.1 AAIPharma Services
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Antibacterial Drug Resistance Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 AAIPharma Services Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 ANTABIO
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Antibacterial Drug Resistance Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 ANTABIO Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Abgentis
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Antibacterial Drug Resistance Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Abgentis Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Abbott Laboratories
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Antibacterial Drug Resistance Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Abbott Laboratories Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Absynth Biologics
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Antibacterial Drug Resistance Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Absynth Biologics Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Achaogen
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Antibacterial Drug Resistance Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Achaogen Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Acino Holdings
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Antibacterial Drug Resistance Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Acino Holdings Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Aventis Pharma
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Antibacterial Drug Resistance Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Aventis Pharma Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Austell Laboratories
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Antibacterial Drug Resistance Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Austell Laboratories Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Assembly Biosciences
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Antibacterial Drug Resistance Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Assembly Biosciences Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 Arpida
    10.12 Demuris
    10.13 Evolva Holding
    10.14 ContraFect
    10.15 Cerexa
    10.16 GSK
    10.17 InterMune
    10.18 Isis Pharmaceuticals
    10.19 Lyndra
    10.20 Microbecide
    10.21 Morphochem
    10.22 Nabriva Therapeutics
    10.23 NanoSafe Coatings
    10.24 Novexel
    10.25 Osel
    10.26 PENDOPHARM
    10.27 Pfizer
    10.28 VenatoRx Pharmaceuticals

11 Antibacterial Drug Resistance Manufacturing Cost Analysis
    11.1 Antibacterial Drug Resistance Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Antibacterial Drug Resistance

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Antibacterial Drug Resistance Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Antibacterial Drug Resistance Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Antibacterial Drug Resistance Market Forecast (2017-2022)
    15.1 Asia-Pacific Antibacterial Drug Resistance Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Antibacterial Drug Resistance Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Antibacterial Drug Resistance Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Antibacterial Drug Resistance Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Antibacterial Drug Resistance Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Antibacterial Drug Resistance Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Antibacterial Drug Resistance Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Antibacterial Drug Resistance Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Antibacterial Drug Resistance Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Antibacterial Drug Resistance Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Antibacterial Drug Resistance Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Antibacterial Drug Resistance Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Antibacterial